Published in J Thyroid Res on June 11, 2012
Common fragile sites: genomic hotspots of DNA damage and carcinogenesis. Int J Mol Sci (2012) 0.87
Environmental and chemotherapeutic agents induce breakage at genes involved in leukemia-causing gene rearrangements in human hematopoietic stem/progenitor cells. Mutat Res (2015) 0.75
New Insights in the Cytogenetic Practice: Karyotypic Chaos, Non-Clonal Chromosomal Alterations and Chromosomal Instability in Human Cancer and Therapy Response. Genes (Basel) (2017) 0.75
Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA (2006) 22.71
Signatures of mutation and selection in the cancer genome. Nature (2010) 9.75
Youth risk behavior surveillance - United States, 2009. MMWR Surveill Summ (2010) 9.63
Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev (2009) 8.08
A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat Genet (2003) 6.03
Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res (1995) 5.72
Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer (2009) 5.55
Chromosome fragile sites. Annu Rev Genet (2007) 4.95
ATR regulates fragile site stability. Cell (2002) 4.74
Use of contraception in the United States: 1982-2008. Vital Health Stat 23 (2010) 4.70
Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells. Science (2000) 4.17
Constitutive fragile sites and cancer. Science (1984) 3.30
Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res (1997) 3.06
DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum Genet (1984) 2.92
Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst (1997) 2.83
Excess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol Biomarkers Prev (1996) 2.76
Cell-type-specific replication initiation programs set fragility of the FRA3B fragile site. Nature (2011) 2.69
Collisions between replication and transcription complexes cause common fragile site instability at the longest human genes. Mol Cell (2011) 2.66
A role for common fragile site induction in amplification of human oncogenes. Cancer Cell (2002) 2.63
Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription. Nat Cell Biol (2009) 2.60
RET/PTC rearrangement in thyroid tumors. Endocr Pathol (2002) 2.42
Mechanisms of therapy-related carcinogenesis. Nat Rev Cancer (2005) 2.30
Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ (2007) 2.28
Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell (1997) 2.28
Replication stress induces tumor-like microdeletions in FHIT/FRA3B. Proc Natl Acad Sci U S A (2007) 2.27
The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Hum Mol Genet (2005) 2.23
Fragile and unstable chromosomes in cancer: causes and consequences. Trends Genet (2001) 2.20
Binge drinking among youths and young adults in the United States: 1979-2006. J Am Acad Child Adolesc Psychiatry (2009) 2.18
Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site. Proc Natl Acad Sci U S A (1998) 2.16
Pesticide exposures and other agricultural risk factors for leukemia among men in Iowa and Minnesota. Cancer Res (1990) 2.03
A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs. Mol Cell (1998) 2.00
Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene (2003) 2.00
Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype--papillary, follicular, and anaplastic: a morphological and epidemiological study. Endocr Pathol (2007) 1.92
Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies. Cancer Epidemiol Biomarkers Prev (2011) 1.86
FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum Mol Genet (1996) 1.84
RET tyrosine kinase signaling in development and cancer. Cytokine Growth Factor Rev (2005) 1.82
Common fragile sites as targets for chromosome rearrangements. DNA Repair (Amst) (2006) 1.82
Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. Cancer Res (2000) 1.82
Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis. Expert Rev Mol Diagn (2008) 1.80
Papillary thyroid cancer incidence in the volcanic area of Sicily. J Natl Cancer Inst (2009) 1.80
Molecular basis for expression of common and rare fragile sites. Mol Cell Biol (2003) 1.78
Replication of a common fragile site, FRA3B, occurs late in S phase and is delayed further upon induction: implications for the mechanism of fragile site induction. Hum Mol Genet (1998) 1.65
Cancer among farmers. Occup Med (1991) 1.62
Alcohol use among pregnant and nonpregnant women of childbearing age - United States, 1991-2005. MMWR Morb Mortal Wkly Rep (2009) 1.55
Increasing world incidence of thyroid cancer: increased detection or higher radiation exposure? Hormones (Athens) (2010) 1.54
Induction of sister chromatid exchanges at common fragile sites. Am J Hum Genet (1987) 1.51
An AT-rich sequence in human common fragile site FRA16D causes fork stalling and chromosome breakage in S. cerevisiae. Mol Cell (2007) 1.51
Depletion of CHK1, but not CHK2, induces chromosomal instability and breaks at common fragile sites. Oncogene (2006) 1.50
"Choking game" awareness and participation among 8th graders--Oregon, 2008. MMWR Morb Mortal Wkly Rep (2010) 1.49
Common fragile sites. Cancer Lett (2005) 1.48
Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma. Oncogene (2006) 1.47
Fragile sites are targets of diverse mutagens and carcinogens. Oncogene (1987) 1.45
A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control (1999) 1.45
BRCA1 is required for common-fragile-site stability via its G2/M checkpoint function. Mol Cell Biol (2004) 1.45
Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res (1995) 1.33
Werner syndrome helicase activity is essential in maintaining fragile site stability. J Cell Biol (2008) 1.31
Genetic alterations in cancer as a result of breakage at fragile sites. Cancer Lett (2003) 1.30
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture. Eur J Endocrinol (2006) 1.29
High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene (1995) 1.29
Replication delay along FRA7H, a common fragile site on human chromosome 7, leads to chromosomal instability. Mol Cell Biol (2000) 1.27
Modeling human metabolism of benzene following occupational and environmental exposures. Cancer Epidemiol Biomarkers Prev (2006) 1.26
DNA polymerase epsilon: aphidicolin inhibition and the relationship between polymerase and exonuclease activity. Biochemistry (1993) 1.24
Explaining the increasing incidence of differentiated thyroid cancer. CMAJ (2007) 1.22
Changing incidence of thyroid cancer. JAMA (2006) 1.21
The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults. J Clin Endocrinol Metab (2000) 1.19
Over half of breakpoints in gene pairs involved in cancer-specific recurrent translocations are mapped to human chromosomal fragile sites. BMC Genomics (2009) 1.17
Fanconi anemia: a disorder defective in the DNA damage response. Int J Hematol (2011) 1.17
Chromosomal instability at common fragile sites in Seckel syndrome. Am J Hum Genet (2004) 1.15
Viral integration and fragile sites in human papillomavirus-immortalized human keratinocyte cell lines. Genes Chromosomes Cancer (1992) 1.12
DNA instability at chromosomal fragile sites in cancer. Curr Genomics (2010) 1.11
Chromosome breakage at a major fragile site associated with P-glycoprotein gene amplification in multidrug-resistant CHO cells. Mol Cell Biol (1994) 1.11
Rare fragile sites. Cytogenet Genome Res (2003) 1.11
Genotoxicity evaluation of estradiol. Mutat Res (1995) 1.11
The Werner syndrome protein: linking the replication checkpoint response to genome stability. Aging (Albany NY) (2011) 1.09
DNA breaks at fragile sites generate oncogenic RET/PTC rearrangements in human thyroid cells. Oncogene (2010) 1.09
RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features. Clin Cancer Res (1998) 1.05
Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment. Br J Cancer (1999) 1.04
Preferential sites for viral integration on mammalian genome. Cancer Genet Cytogenet (1989) 1.03
DNA structure and the Werner protein modulate human DNA polymerase delta-dependent replication dynamics within the common fragile site FRA16D. Nucleic Acids Res (2009) 1.02
Cancer incidence in the U.S. Air Force: 1989-2002. Aviat Space Environ Med (2006) 1.02
Fragile sites: overview, occurrence in acute nonlymphocytic leukemia and effects of caffeine on expression. Cancer Genet Cytogenet (1986) 1.00
Secondary malignancies following cancer chemotherapy. Acta Oncol (1994) 0.99
Interphase chromosome folding determines spatial proximity of genes participating in carcinogenic RET/PTC rearrangements. Oncogene (2006) 0.99
Direct correlation between FRA3B expression and cigarette smoking. Genes Chromosomes Cancer (2002) 0.99
Thyroid carcinoma presenting in childhood or after treatment of childhood malignancies: An institutional experience and review of the literature. J Pediatr Surg (2003) 0.93
Genotoxicity and carcinogenicity studies of antihypertensive agents. Mutat Res (2006) 0.93
Analysis of replication timing at the FRA10B and FRA16B fragile site loci. Chromosome Res (2000) 0.91
Protecting genomic integrity during DNA replication: correlation between Werner's and Bloom's syndrome gene products and the MRE11 complex. Hum Mol Genet (2002) 0.90
Distribution of volatile organic compounds in Sicilian groundwaters analysed by head space-solid phase micro extraction coupled with gas chromatography mass spectrometry (SPME/GC/MS). Water Res (2008) 0.90
Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma. Hum Mol Genet (1995) 0.89
Inhibition of topoisomerase I prevents chromosome breakage at common fragile sites. DNA Repair (Amst) (2010) 0.89
Forty-year experience with second malignancies after treatment of childhood cancer: analysis of outcome following the development of the second malignancy. J Pediatr Surg (1993) 0.89
Replication timing of two human common fragile sites: FRA1H and FRA2G. Cytogenet Genome Res (2008) 0.88
Increased fragile sites and sister chromatid exchanges in bone marrow and peripheral blood of young cigarette smokers. Cancer Res (1987) 0.88
Comparison of the breakpoint regions of ELE1 and RET genes involved in the generation of RET/PTC3 oncogene in sporadic and in radiation-associated papillary thyroid carcinomas. Genomics (1997) 0.86
Variation in the expression of aphidicolin-induced fragile sites in human lymphocyte cultures. Hum Genet (1987) 0.86
Organophosphate-based pesticides and genetic damage implicated in bladder cancer. Cancer Genet Cytogenet (2002) 0.83
Multiple hamartoma syndrome with osteosarcoma. Arch Pathol Lab Med (1993) 0.82
L3MBTL1, a histone-methylation-dependent chromatin lock. Cell (2007) 3.70
Evidence of cis-acting factors in replication-mediated trinucleotide repeat instability in primate cells. Nat Genet (2002) 2.81
The functional interaction of the hepatitis C virus helicase molecules is responsible for unwinding processivity. J Biol Chem (2004) 1.76
Slipped-strand DNAs formed by long (CAG)*(CTG) repeats: slipped-out repeats and slip-out junctions. Nucleic Acids Res (2002) 1.64
Functional analysis of the subunits of the chromatin assembly factor RSF. Mol Cell Biol (2003) 1.56
Determinants of R-loop formation at convergent bidirectionally transcribed trinucleotide repeats. Nucleic Acids Res (2010) 1.32
Self-association of collagen triple helic peptides into higher order structures. J Biol Chem (2006) 1.30
Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability. J Med Chem (2005) 1.28
Over half of breakpoints in gene pairs involved in cancer-specific recurrent translocations are mapped to human chromosomal fragile sites. BMC Genomics (2009) 1.17
DNA instability at chromosomal fragile sites in cancer. Curr Genomics (2010) 1.11
Secondary structure formation and DNA instability at fragile site FRA16B. Nucleic Acids Res (2010) 1.11
Highly compacted chromatin formed in vitro reflects the dynamics of transcription activation in vivo. Mol Cell (2010) 1.08
Chromatin structure can strongly facilitate enhancer action over a distance. Proc Natl Acad Sci U S A (2006) 1.00
Effect of CAT or AGG interruptions and CpG methylation on nucleosome assembly upon trinucleotide repeats on spinocerebellar ataxia, type 1 and fragile X syndrome. J Biol Chem (2004) 0.90
Sequence dependence of kinetics and morphology of collagen model peptide self-assembly into higher order structures. Protein Sci (2008) 0.90
The ATTCT repeats of spinocerebellar ataxia type 10 display strong nucleosome assembly which is enhanced by repeat interruptions. Gene (2008) 0.86
Role of DNA secondary structures in fragile site breakage along human chromosome 10. Hum Mol Genet (2013) 0.85
Friedreich's ataxia GAA.TTC duplex and GAA.GAA.TTC triplex structures exclude nucleosome assembly. J Mol Biol (2008) 0.84
Human fragile site FRA16B DNA excludes nucleosomes in the presence of distamycin. J Biol Chem (2002) 0.82
ATR preferentially interacts with common fragile site FRA3B and the binding requires its kinase activity in response to aphidicolin treatment. Mutat Res (2010) 0.81
Two breakpoint clusters at fragile site FRA3B form phased nucleosomes. Genome Res (2004) 0.79
DNA topoisomerases participate in fragility of the oncogene RET. PLoS One (2013) 0.79
Drug self-association modulates the cellular bioavailability of DNA minor groove-directed terbenzimidazoles. J Med Chem (2006) 0.76
CBFB and MYH11 in inv(16)(p13q22) of acute myeloid leukemia displaying close spatial proximity in interphase nuclei of human hematopoietic stem cells. Genes Chromosomes Cancer (2011) 0.75
CAG nucleotide repeat profiles in persons with schizophrenia or schizoaffective disorders with and without tardive dyskinesia: pilot study. Am J Med Genet B Neuropsychiatr Genet (2004) 0.75